Captrust Financial Advisors Chembio Diagnostics, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $545 - $1,275	-500 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$2.06 - $5.34 $339 - $881	-165 Reduced 24.81%	500 $1,000
Q2 2021 Aug 16, 2021	BUY	$2.88 - $5.64 $1,189 - $2,329	413 Added 163.89%	665 $2,000
Q1 2021 May 17, 2021	BUY	$3.4 - $7.97 $856 - $2,008	252 New	252 $1,000
Q3 2020 Nov 17, 2020	SELL	$3.28 - $5.93 $820 - $1,482	-250 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $795 - $3,885	250 New	250 $1,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.